PUBLISHER: The Business Research Company | PRODUCT CODE: 1750946
PUBLISHER: The Business Research Company | PRODUCT CODE: 1750946
Cold remedies are treatments designed to relieve symptoms of the common cold, including congestion, cough, and sore throat. These remedies may include medications, natural therapies, and supportive care, aiming to enhance comfort and promote recovery, though they do not cure the viral infection itself.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary drug types used in cold remedies include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines work by blocking histamine receptors to ease allergy-related symptoms such as sneezing, itching, and nasal congestion. Cold remedies come in various dosage forms, including oral syrups, tablets and pills, nasal drops, lozenges, and others. They are distributed through multiple channels such as hospital pharmacies, retail pharmacies, drug stores, supermarkets and hypermarkets, as well as e-commerce and online pharmacies.
The cold remedies market research report is one of a series of new reports from The Business Research Company that provides cold remedies market statistics, including the cold remedies industry global market size, regional shares, competitors with the cold remedies market share, detailed cold remedies market segments, market trends, and opportunities, and any further data you may need to thrive in the cold remedies industry. These cold remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cold remedies market size has grown strongly in recent years. It will grow from$9.31 billion in 2024 to $9.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to the increasing prevalence of respiratory infections, a growing geriatric population, rising demand for effective combination products, an increased shift from prescription (Rx) to over-the-counter (OTC) medications, and heightened consumer demand for fast and effective symptom relief.
The cold remedies market size is expected to see strong growth in the next few years. It will grow to$12.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth projected for the forecast period can be attributed to increased investment in research and development, growing awareness of preventive healthcare, a rise in holistic health approaches, increasing health consciousness among consumers, and supportive government policies. Key trends expected during this period include the emergence of innovative solutions, technological advancements, novel product formulations, personalized medicine, and a shift toward tailored, immune-boosting solutions.
The increasing incidence of respiratory infections is anticipated to drive the growth of the cold remedies market in the coming years. Respiratory infections are illnesses that impact the respiratory system-such as the sinuses, throat, airways, and lungs-and are caused by viruses, bacteria, or other pathogens. A surge in these infections is largely attributed to weakened immune systems following prolonged pandemic-related lockdowns and reduced exposure to common viruses due to social distancing. Cold remedies play a crucial role in easing symptoms such as congestion, cough, and sore throat, offering symptomatic relief while the body recovers. For example, in March 2023, the Office for National Statistics, a UK-based government agency, reported that COVID-19 infections rose in England, with approximately 2.66% of the population testing positive (equivalent to 1 in 40 individuals), and hospital admissions increased to 10.62 per 100,000 people. Hence, the rising prevalence of respiratory infections is contributing to the expansion of the cold remedies market.
Key players in the cold remedies market are focusing on the development of innovative clean-label products to cater to rising consumer demand for safer, more natural alternatives. Clean cough and cold medicines are formulated without artificial dyes, sweeteners, preservatives, or common allergens, instead utilizing natural or organic ingredients to deliver effective symptom relief. For instance, in September 2023, Genexa Inc., a US-based healthcare company, launched new clean-label cough and cold medicines for children, including the Kids' Multi-Symptom Cold And Flu and the Kids' Daytime + Nighttime Cough Relief Value Pack. These formulations exclude artificial dyes, parabens, sweeteners, and allergens, and incorporate organic agave syrup as a natural base. They maintain the effectiveness of conventional medications while offering a non-toxic, clean alternative.
In February 2024, Cipla Limited, an India-based pharmaceutical firm, acquired Actor Pharma for $48.6 million. This acquisition is part of Cipla's strategy to enhance its over-the-counter (OTC) product lineup, broaden its consumer healthcare offerings, and solidify its footprint in the self-care and wellness space. Actor Pharma (Pty) Limited, based in South Africa, is known for manufacturing expectorants and contributes valuable expertise and product capabilities to Cipla's growing OTC portfolio.
Major players in the cold remedies market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Haleon plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Prestige Brands Holdings Inc., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Centurion Remedies Private Limited, Himalaya Wellness Company, Genexa Inc., and Fibovil Pharmaceuticals Pvt. Ltd.
North America was the largest region in the cold remedies market in 2024. The regions covered in cold remedies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cold remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cold remedies market consists of sales of inhalers, topical rubs, throat sprays, homeopathic remedies, and vitamin supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cold Remedies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cold remedies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cold remedies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold remedies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.